RLAY
Price
$3.60
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
622.35M
38 days until earnings call
TPST
Price
$7.13
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
26.26M
33 days until earnings call
Interact to see
Advertisement

RLAY vs TPST

Header iconRLAY vs TPST Comparison
Open Charts RLAY vs TPSTBanner chart's image
Relay Therapeutics
Price$3.60
Change-$0.00 (-0.00%)
Volume$281
Capitalization622.35M
Tempest Therapeutics
Price$7.13
Change-$0.00 (-0.00%)
Volume$48.65K
Capitalization26.26M
RLAY vs TPST Comparison Chart in %
Loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RLAY vs. TPST commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLAY is a Buy and TPST is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (RLAY: $3.60 vs. TPST: $7.13)
Brand notoriety: RLAY and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLAY: 0% vs. TPST: 37%
Market capitalization -- RLAY: $622.35M vs. TPST: $26.26M
RLAY [@Biotechnology] is valued at $622.35M. TPST’s [@Biotechnology] market capitalization is $26.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLAY’s FA Score shows that 1 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • RLAY’s FA Score: 1 green, 4 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, RLAY is a better buy in the long-term than TPST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLAY’s TA Score shows that 4 TA indicator(s) are bullish while TPST’s TA Score has 4 bullish TA indicator(s).

  • RLAY’s TA Score: 4 bullish, 3 bearish.
  • TPST’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than TPST.

Price Growth

RLAY (@Biotechnology) experienced а +8.43% price change this week, while TPST (@Biotechnology) price change was +0.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

RLAY is expected to report earnings on Aug 12, 2025.

TPST is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($622M) has a higher market cap than TPST($26.3M). RLAY YTD gains are higher at: -12.621 vs. TPST (-34.277). TPST has higher annual earnings (EBITDA): -43.32M vs. RLAY (-373.07M). RLAY has more cash in the bank: 710M vs. TPST (21.5M). TPST has less debt than RLAY: TPST (13.1M) vs RLAY (47.2M). RLAY has higher revenues than TPST: RLAY (7.68M) vs TPST (0).
RLAYTPSTRLAY / TPST
Capitalization622M26.3M2,365%
EBITDA-373.07M-43.32M861%
Gain YTD-12.621-34.27737%
P/E RatioN/AN/A-
Revenue7.68M0-
Total Cash710M21.5M3,302%
Total Debt47.2M13.1M360%
FUNDAMENTALS RATINGS
TPST: Fundamental Ratings
TPST
OUTLOOK RATING
1..100
43
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RLAYTPST
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CVKD12.980.54
+4.34%
Cadrenal Therapeutics Inc
ATEN20.140.38
+1.92%
A10 Networks
NECB24.680.37
+1.52%
NorthEast Community Bancorp
CRSP52.170.50
+0.97%
CRISPR Therapeutics AG
ET17.970.16
+0.90%
Energy Transfer LP

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been loosely correlated with PHIO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TPST jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
N/A
PHIO - TPST
49%
Loosely correlated
-3.23%
ABCZF - TPST
48%
Loosely correlated
N/A
ARCT - TPST
39%
Loosely correlated
+1.17%
RXRX - TPST
38%
Loosely correlated
+1.15%
MGTX - TPST
38%
Loosely correlated
+8.53%
More